CristinaITruicaMD

Oncology • Hershey, PA

Breast Cancer, Hematologic Oncology

Associate Professor, Medicine, Pennsylvania State University College of Medicine

Join to view full profile

Dr. Truica is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Truica's full profile

Already have an account?

Office
500 University Dr
Attn: Credentialing
Hershey, PA 17033
Phone+1 800-243-1455

Fax+1 717-531-5076

Education & Training

Georgetown University HospitalFellowship, Medical Oncology, 1995 - 1998
MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 1996 - 1997
Wellspan Health/York HospitalResidency, Internal Medicine, 1993 - 1995
Rutgers Health/Jersey City Medical CenterInternship, Internal Medicine, 1992 - 1993
Carol Davila University of Medicine and PharmacyClass of 1989

Certifications & Licensure

PA State Medical License 1994 - 2024
MD State Medical License 2004 - 2011
TN State Medical License 2002 - 2006
DC State Medical License 1996 - 2002
VA State Medical License 1996 - 2002

Clinical Trials

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer Start of enrollment: 2013 Feb 01
Completed
Phase 2
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI Start of enrollment: 2013 May 31
Completed
Phase 2
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
Completed
Phase 3
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
Active, not recruiting
Phase 3
Study of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer. Start of enrollment: 2015 Jun 09
Completed
Phase 3
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

93 citations
Flexible Micro Spring Array Device for High-Throughput Enrichment of Viable Circulating Tumor Cells
Ramdane Harouaka, Ming Da Zhou, Yin Ting Yeh, Waleed J. Khan, Avisnata Das
Clinical Chemistry. 2014-02-01
402 citations
Acoustic separation of circulating tumor cells
Peng Li, Zhangming Mao, Zhangli Peng, Lanlan Zhou, Yuchao Chen
Proceedings of the National Academy of Sciences of the United States of America. 2015-04-21
6 citations
Impact of lack of surgery on outcomes in elderly women with nonmetastatic breast cancer-A surveillance, epidemiology, and end results 18 population based study
Ming Yin, Claire F. Verschraegen, Vinh Hung Vincent, Sandipkumar Patel, Tiffany L. George
Medicine. 2020-01-01